Bristol-Myers Squibb | BMY

Stock Price
61.12
Daily Change
-0.56 -0.91%
Monthly
-1.82%
Yearly
37.69%
Q4 Forecast
58.49

EPS Reference Time Actual Consensus Previous
2026-10-29 FY2026Q3 AM 1.60 1.63
2026-07-30 FY2026Q2 AM 2.04 1.61 1.46
2026-04-30 FY2026Q1 AM 1.58 1.45 1.80
2026-02-05 FY2025Q4 AM 1.26 1.61 1.67
2025-10-30 FY2025Q3 AM 1.63 1.69 1.80



Peers Price Chg Day Year Date
AbbVie 284.80 -4.28 -1.48% 24.54% Oct/21
Abbott 100.51 -1.94 -1.89% -21.45% Oct/21
ALKERMES 43.48 -0.63 -1.43% 39.85% Oct/21
Amgen 438.34 -0.60 -0.14% 48.10% Oct/21
AstraZeneca 12,614.00 -4.00 -0.03% 0.59% Oct/21
Biogen 240.98 -2.12 -0.87% 63.13% Oct/21
Bristol-Myers Squibb 61.12 -0.56 -0.91% 37.69% Oct/21
Coherus Biosciences 1.02 0.02 2.00% -39.29% Oct/21
Gilead Sciences 153.58 -2.93 -1.87% 26.44% Oct/21
GlaxoSmithKline 1,868.00 -0.50 -0.03% 13.04% Oct/21

Indexes Price Day Year Date
US500 7705 44.60 0.58% 14.35% Oct/22

Bristol-Myers Squibb traded at $61.12 this Wednesday October 21st, decreasing $0.56 or 0.91 percent since the previous trading session. Looking back, over the last four weeks, Bristol-Myers Squibb lost 1.82 percent. Over the last 12 months, its price rose by 37.69 percent. Looking ahead, we forecast Bristol-Myers Squibb to be priced at 58.49 by the end of this quarter and at 54.86 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.



News Stream
Bristol-Myers Squibb Shares Hit 10-week Low
Bristol-Myers Squibb shares decreased to 60.48 USD, the lowest since July 2026. Over the past 4 weeks, Bristol-Myers Squibb lost 9.16%, and in the last 12 months, it increased 34.4%.
2026-10-02
Bristol-Myers Squibb Stock Price Hits 4-week Low
Bristol-Myers Squibb shares decreased to 63.35 USD, the lowest since August 2026. Over the past 4 weeks, Bristol-Myers Squibb lost 0.41%, and in the last 12 months, it increased 37.32%.
2026-09-11
Bristol-Myers Squibb Stock Price Hits 3-year High
Bristol-Myers Squibb shares increased to 68.11 USD, the highest since May 2023. Over the past 4 weeks, Bristol-Myers Squibb gained 12.92%, and in the last 12 months, it increased 40.53%.
2026-08-19